Cold storage treatment for donated kidneys before transplant
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a special cold storage solution and machine to keep donated kidneys healthy before they are transplanted. It may help the kidneys work better after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be on the kidney transplant waiting list.
- You must be healthy enough for a kidney transplant, in your doctor's opinion.
- You must not be pregnant or planning to become pregnant during the study.
- You must not be getting a kidney from a living donor.
- You must not be getting a kidney together with another organ or a dual kidney transplant.
- You must not have very high levels of antibodies that make it hard to find a matching kidney.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special solution given to the donor kidney during storage and transport, which may help protect the kidney before transplant. It is for adults with kidney failure receiving a deceased donor kidney.
This study tests whether a newer method of preserving donor kidneys (called HMPO2 with NRP) can improve outcomes compared with the standard NRP method alone. If you are getting a kidney from a donor after circulatory death, this could help your transplant succeed.
This trial checks whether a special preservation machine (called machine perfusion) can predict how well a donated kidney will work after transplant. Participation helps doctors better match kidneys to patients and improve transplant success.
This study looks at whether testing the fluid used to store donated organs can help doctors find and treat infections earlier, possibly leading to better outcomes after a liver or kidney transplant.
This study tests whether giving a special mix of donor immune cells along with immune-suppressing medicines right after a kidney transplant can help the body accept the new kidney without long-term anti-rejection drugs. It aims to reduce the need for daily transplant medications.
This trial tests a machine method that keeps a donated kidney working “outside the body” so it may be better repaired before transplant. It is designed for certain first/second kidney transplants using specific donor types and storage methods.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.